EAM
ALNY icon

EFG Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

EFG Asset Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$7.44M Sell
16,335
-4,827
-23% -$1.97M 0.96% 17
2025
Q2 		$6.89M Sell
21,162
-3,529
-14% -$977K 0.97% 13
2025
Q1 		$6.67M Sell
24,691
-1,955
-7% -$502K 1.11% 13
2024
Q4 		$6.28M Buy
26,646
+6,031
+29% +$1.59M 0.86% 22
2024
Q3 		$5.67M Buy
20,615
+2,031
+11% +$529K 0.95% 16
2024
Q2 		$4.52M Sell
18,584
-1,362
-7% -$215K 0.78% 26
2024
Q1 		$2.98M Sell
19,946
-3,740
-16% -$624K 0.51% 64
2023
Q4 		$4.54M Sell
23,686
-4,165
-15% -$709K 0.86% 28
2023
Q3 		$4.93M Sell
27,851
-300
-1% -$57.2K 1.17% 20
2023
Q2 		$5.35M Buy
28,151
+416
+1% +$82.5K 1.15% 15
2023
Q1 		$5.56M Sell
27,735
-849
-3% -$178K 1.23% 15
2022
Q4 		$6.8M Sell
28,584
-170
-0.6% -$36.3K 1.53% 7
2022
Q3 		$5.75M Buy
28,754
+1,880
+7% +$359K 1.33% 15
2022
Q2 		$3.92M Sell
26,874
-12,321
-31% -$1.75M 0.83% 39
2022
Q1 		$6.4M Buy
+39,195
New +$5.97M 0.96% 33

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

EFG Asset Management's ALNY Position: Q3 2025 in Review

EFG Asset Management reduced its Alnylam Pharmaceuticals (ALNY) stake by 23% in Q3 2025, selling an estimated $1.97M and leaving 16,335 shares worth $7.44M. The position accounts for 0.96% of the portfolio, ranked #17.

EFG Asset Management first reported a position in ALNY in Q1 2022 and has held it in 15 quarters since. 821 funds tracked by Wall St. Rank hold ALNY as of Q3 2025.

  • EFG Asset Management held 16,335 shares of Alnylam Pharmaceuticals worth $7.44M as of Q3 2025.
  • EFG Asset Management sold 4,827 Alnylam Pharmaceuticals shares in Q3 2025, an estimated $1.97M.
  • Alnylam Pharmaceuticals made up 0.96% of EFG Asset Management's portfolio in Q3 2025, its #17 holding.
  • EFG Asset Management first reported a position in Alnylam Pharmaceuticals in Q1 2022 and has held it in 15 quarters since.
  • 821 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2025.

Based on EFG Asset Management's 13F filing for Q3 2025, filed 3 Nov 2025.